Evidence map›Paper›PMID 34079905›Full record

ArticleACS central science2021

Continuum Crystallization Model Derived from Pharmaceutical Crystallization Mechanisms.

Yael Tsarfati, Idan Biran, Eduard Wiedenbeck, Lothar Houben, Helmut Cölfen, Boris Rybtchinski

Abstract read
In one paragraph

Article in ACS central science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. The Molecular Basis of Growth Control in Guanine Crystals.Small (Weinheim an der Bergstrasse, Germany) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Nucleation of glucose isomerase protein crystals in a nonclassical disguise: The role of crystalline precursors.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yael TsarfatiDepartment of Molecular Chemistry and Materials Science and Department of Chemical Research Support, Weizmann Institute of Science, Rehovot 76100, Israel.
Idan BiranDepartment of Molecular Chemistry and Materials Science and Department of Chemical Research Support, Weizmann Institute of Science, Rehovot 76100, Israel.
Eduard WiedenbeckPhysical Chemistry, Department of Chemistry, University of Konstanz, Universitätsstraße 10, 78457 Konstanz, Germany.
Lothar HoubenDepartment of Molecular Chemistry and Materials Science and Department of Chemical Research Support, Weizmann Institute of Science, Rehovot 76100, Israel.ORCID 0000-0003-0200-3611
Helmut CölfenPhysical Chemistry, Department of Chemistry, University of Konstanz, Universitätsstraße 10, 78457 Konstanz, Germany.ORCID 0000-0002-1148-0308
Boris RybtchinskiDepartment of Molecular Chemistry and Materials Science and Department of Chemical Research Support, Weizmann Institute of Science, Rehovot 76100, Israel.ORCID 0000-0002-2071-8429

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The crystallization mechanisms of organic molecules in solution are not well-understood. The mechanistic scenarios where crystalline order evolves directly from the molecularly dissolved state ("classical") and from initially formed amorphous intermediates ("nonclassical") are suggested and debated. Here, we studied crystallization mechanisms of two widely used analgesics, ibuprofen (IbuH) and etoricoxib (ETO), using direct cryogenic transmission electron microscopy (cryo-TEM) imaging. In the IbuH case, parallel crystallization pathways involved diverse phases of high and low density, in which the instantaneous formation of final crystalline order was observed. ETO crystallization started from well-defined round-shaped amorphous intermediates that gradually evolved into crystals. This mechanistic diversity is rationalized by introducing a continuum crystallization paradigm: order evolution depends on ordering in the initially formed intermediates and efficiency of molecular rearrangements within them, and there is a continuum of states related to the initial order and rearrangement rates. This model provides a unified view of crystallization mechanisms, encompassing classical and nonclassical pictures.

Identifiers

PMID34079905
PMCPMC8161475

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.